Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is
- To characterize the pharmacokinetic profile of the Ramipril 10 mg capsules relative to
that of ALTACE@ 10 mg capsules in healthy, adult, human, male subjects under non-fasting
conditions and to assess the bioequivalence.
- To monitor the safety of the subjects.